Is steroid therapy ever of benefit to patients in the intensive care unit going into septic shock

Interactive Cardiovascular and Thoracic Surgery

Volumn 7, Issue 5, 2008, Pages 898-905

  Richardson, Lydia ^a   Hunter, Steven ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hydrocortisone; Intensive care unit; Mortality; Septic shock; Shock reversal; Steroid

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; PLACEBO; STEROID;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE REDUCTION; HEART RATE; HUMAN; INTENSIVE CARE; LEUKOCYTE ACTIVATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MORTALITY; PHAGOCYTE; PRIORITY JOURNAL; SEPTIC SHOCK; STEROID THERAPY; SURGICAL RISK; THORAX SURGERY; VASCULAR RESISTANCE;

ADULT; AGED; AGED, 80 AND OVER; BENCHMARKING; CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; FEMALE; HEMODYNAMICS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PATIENT SELECTION; PHAGOCYTOSIS; SHOCK, SEPTIC; STEROIDS; TREATMENT OUTCOME;

EID: 53349144763     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.185504     Document Type: Article

References (18)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interat CardioVasc Thorac Surg 2003;2:405-409.
2. Rinaldi S, Adembri C, Grechi S, Gaudio R. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 2006; 34:2334-2339.
3. Kaufman I, Briegel J, Schliephake F, Hoezel A, Chouker A, Hummel T, Schelling G, Thiel M. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependant neutrophil functions. Intensive Care Med 2008;34:334-349.
4. Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33:2457-2464.
5. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124.
6. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of low dose hydrocortisone in septic shock. Am J Respir Crit Care Med 2003;167:512-520.
7. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. Effects of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc 2002;288:862-871.
8. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomised, double-blind, single-centre study. Crit Care Med 1999;27:723-732.
9. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650.
10. Raurich JM, Llompart-Pou JA, Ibanez J, Frontera G, Perez O, Garcia L, Ayestaran JI. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients. J Crit Care 2007;22:324-330.
11. de Jong MFC, Beishuizen A, Spijkstra JJ, Groeneveld J. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock. Crit Care Med 2007;35:1896-1903.
12. Annane D, Bellissant E, Bollaert PR, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock. Cochrane Database of Syst Rev 2004;Issue 1.
13. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004;141:47-56.
14. Cronin L, Cook D, Carlet J, Heyland D, King D, Lansang MA, Fisher CJ. Corticosteroid treatment for sepsis: a critical appraisal and metaanalysis of the literature. Crit Care Med 1995;23:1430-1439.
15. Lefering R, Neugebauer E. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-1303.
16. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker M, Ramsay G, Zimmerman JL, Vincent J-L, Levy M. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
17. Annane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care 2005;11:449-453.
18. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-734.